摘要 |
The invention relates to polymorphic forms of 5-(3-(ethylsulfonyl)phenyl)-3,8-dimethyl-N-(1-methylpiperidin-4-yl)-9h-pyrido[2,3-b]indole-7-carboxamide (referred to herein as Compound I), which has the formula: (A). The invention also relates to compositions thereof and methods for the preparation of the polymorphs of Compound I, and kits and articles of manufacture of the compositions, and methods of using the compositions to treat various diseases. |
申请人 |
TAKEDA PHARMACEUTICAL COMPANY LIMITED;ISBESTER, PAUL;PALMER, GRANT, J.;MOBELE, BINGIDIMI, I.;SALSBURY, JONATHON, S.;ULYSEE, LUCKNER |
发明人 |
ISBESTER, PAUL;PALMER, GRANT, J.;MOBELE, BINGIDIMI, I.;SALSBURY, JONATHON, S.;ULYSEE, LUCKNER |